BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35220720)

  • 1. Targeting the S2 Subsite Enables the Structure-Based Discovery of Novel Highly Selective Factor XIa Inhibitors.
    Yao N; Jia Z; Tian Y; Hou S; Yang X; Han J; Duan Y; Liao C; Kong Y; Xie Z
    J Med Chem; 2022 Mar; 65(5):4318-4334. PubMed ID: 35220720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIa Inhibitors in Anticoagulation Therapy: Recent Advances and Perspectives.
    Xie Z; Meng Z; Yang X; Duan Y; Wang Q; Liao C
    J Med Chem; 2023 Apr; 66(8):5332-5363. PubMed ID: 37037122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XIa inhibitors: A review of the patent literature.
    Al-Horani RA; Desai UR
    Expert Opin Ther Pat; 2016; 26(3):323-45. PubMed ID: 26881476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis for Activity and Specificity of an Anticoagulant Anti-FXIa Monoclonal Antibody and a Reversal Agent.
    Ely LK; Lolicato M; David T; Lowe K; Kim YC; Samuel D; Bessette P; Garcia JL; Mikita T; Minor DL; Coughlin SR
    Structure; 2018 Feb; 26(2):187-198.e4. PubMed ID: 29336885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212).
    Pinto DJP; Orwat MJ; Smith LM; Quan ML; Lam PYS; Rossi KA; Apedo A; Bozarth JM; Wu Y; Zheng JJ; Xin B; Toussaint N; Stetsko P; Gudmundsson O; Maxwell B; Crain EJ; Wong PC; Lou Z; Harper TW; Chacko SA; Myers JE; Sheriff S; Zhang H; Hou X; Mathur A; Seiffert DA; Wexler RR; Luettgen JM; Ewing WR
    J Med Chem; 2017 Dec; 60(23):9703-9723. PubMed ID: 29077405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, expression and biological evaluation of DX-88mut as a novel selective factor XIa inhibitor for antithrombosis.
    Sun F; Wang W; Li Z; Li Y; Guo W; Kong Y
    Bioorg Chem; 2024 Jan; 142():106951. PubMed ID: 37924755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
    Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
    J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel proline based factor XIa selective inhibitors as leads for potential new anticoagulants.
    Hussain Z; Cooke AJ; Neelamkavil S; Brown L; Carswell E; Geissler WM; Guo Z; Hawes B; Kelly TM; Kiyoi Y; Lai K; Lesburg C; Pow E; Zang Y; Wood HB; Edmondson SD; Liu W
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127072. PubMed ID: 32340773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonated non-saccharide molecules and human factor XIa: Enzyme inhibition and computational studies.
    Al-Horani RA; Parsaeian E; Mohammad M; Mottamal M
    Chem Biol Drug Des; 2022 Jul; 100(1):64-79. PubMed ID: 35377529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-Based Lead Generation of 5-Phenyl-1
    Wei Q; Zheng Z; Zhang S; Zheng X; Meng F; Yuan J; Xu Y; Huang C
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30103465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the discovery and development of factor XI/XIa inhibitors.
    Al-Horani RA; Afosah DK
    Med Res Rev; 2018 Sep; 38(6):1974-2023. PubMed ID: 29727017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma.
    Modrzycka S; Kołt S; Adams TE; Potoczek S; Huntington JA; Kasperkiewicz P; Drąg M
    J Med Chem; 2023 Mar; 66(6):3785-3797. PubMed ID: 36898159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity.
    Chen W; Carvalho LP; Chan MY; Kini RM; Kang TS
    J Thromb Haemost; 2015 Feb; 13(2):248-61. PubMed ID: 25418421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel FXIa inhibitors with 2-phenyl-1H-imidazole-5-carboxamide moiety as P1 fragment.
    Lei Y; Zhang B; Zhang Y; Dai X; Duan Y; Mao Q; Gao J; Yang Y; Bao Z; Fu X; Ping K; Yan C; Mou Y; Wang S
    Eur J Med Chem; 2021 Aug; 220():113437. PubMed ID: 33894565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Chromen-7-yl Furan-2-Carboxylate as a Potent and Selective Factor XIa Inhibitor.
    Obaidullah AJ; Al-Horani RA
    Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):40-48. PubMed ID: 28552062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.
    Al-Horani RA; Abdelfadiel EI; Afosah DK; Morla S; Sistla JC; Mohammed B; Martin EJ; Sakagami M; Brophy DF; Desai UR
    J Thromb Haemost; 2019 Dec; 17(12):2110-2122. PubMed ID: 31397071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design.
    Fjellström O; Akkaya S; Beisel HG; Eriksson PO; Erixon K; Gustafsson D; Jurva U; Kang D; Karis D; Knecht W; Nerme V; Nilsson I; Olsson T; Redzic A; Roth R; Sandmark J; Tigerström A; Öster L
    PLoS One; 2015; 10(1):e0113705. PubMed ID: 25629509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia.
    Kar S; Mottamal M; Al-Horani RA
    ChemistryOpen; 2020 Nov; 9(11):1161-1172. PubMed ID: 33204588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups.
    Corte JR; Pinto DJP; Fang T; Osuna H; Yang W; Wang Y; Lai A; Clark CG; Sun JH; Rampulla R; Mathur A; Kaspady M; Neithnadka PR; Li YC; Rossi KA; Myers JE; Sheriff S; Lou Z; Harper TW; Huang C; Zheng JJ; Bozarth JM; Wu Y; Wong PC; Crain EJ; Seiffert DA; Luettgen JM; Lam PYS; Wexler RR; Ewing WR
    J Med Chem; 2020 Jan; 63(2):784-803. PubMed ID: 31833761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical Interactions.
    Xu G; Liu Z; Wang X; Lu T; DesJarlais RL; Thieu T; Zhang J; Devine ZH; Du F; Li Q; Milligan CM; Shaffer P; Cedervall PE; Spurlino JC; Stratton CF; Pietrak B; Szewczuk LM; Wong V; Steele RA; Bruinzeel W; Chintala M; Silva J; Gaul MD; Macielag MJ; Nargund R
    J Med Chem; 2022 Aug; 65(15):10419-10440. PubMed ID: 35862732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.